Cartalax (20mg Cartilage Bioregulator)

What it is: Cartalax is a synthetic short-chain bioregulator tripeptide comprising the sequence Ala-Glu-Asp (AED). Originally identified through Russian peptide bioregulator research programs, it is engineered to mimic endogenous peptide fragments that regulate connective tissue cellular homeostasis and cartilage differentiation.

How it works: In human chondrocyte cultures and organotypic cartilage explants, Cartalax penetrates cellular and nuclear membranes to interact with histone proteins, selectively upregulating gene expression of Type II collagen and aggrecan while suppressing catabolic matrix metalloproteinases (MMP-1, MMP-13). This restores physiological equilibrium between extracellular matrix synthesis and proteolytic breakdown, preserving structural integrity under continuous mechanical strain.

Why researchers study it: Investigated for chondrocyte cellular preservation, osteoarthritis pathology models, intervertebral disc degeneration, and acceleration of soft tissue remodeling at tendon-bone junctions.